# US 11,298,484 B2 · Method and systems for executing nasal high flow therapy with settings determined from flow outputs during a previous ventilation mode > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 11,298,484 B2 - Document ID: US11298484B2 - Status: Granted - Kind: B2 - Application number: 15/979,276 - Filed: 2018-05-14 - Published: 2019-11-14 - Granted: 2022-04-12 - Earliest claimed: 2018-05-14 - Assignees: General Electric Company - Applicants: General Electric Company - Inventors: Timothy Patrick McCormick; James Hanrahan - Web page: https://patentgrep.com/patent/US11298484B2 ## CPC - A61M 16/0096: {High frequency jet ventilation} - A61B 5/087: Measuring breath flow - A61M 16/0057: {Pumps therefor} - A61M 16/024: {including calculation means, e.g. using a processor} - A61M 16/026: {specially adapted for predicting, e.g. for determining an information representative of a flow limitation during a ventilation cycle by using a root square technique or a regression analysis} - A61M 16/0672: {Nasal cannula assemblies for oxygen therapy} - A61M 16/125: {Diluting primary gas with ambient air} - A61B 5/083: Measuring rate of metabolism by using breath test, e.g. measuring rate of oxygen consumption - A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)} - A61B 2562/0247: Pressure sensors - A61M 2016/0027: {pressure meter} - A61M 2016/0036: {in the breathing tube and used in both inspiratory and expiratory phase} - A61M 2016/0039: {in the inspiratory circuit} - A61M 2016/1025: {the O2 concentration} - A61M 2016/103: {the CO2 concentration} - A61M 2202/0208: Oxygen - A61M 2205/3334: Measuring or controlling the flow rate - A61M 2205/502: User interfaces, e.g. screens or keyboards - A61M 2210/0618: Nose - A61M 2230/40: Respiratory characteristics - A61M 2230/432: partial CO2 pressure (P-CO2) - A61M 2230/435: partial O2 pressure (P-O2) - A61M 2240/00: Specially adapted for neonatal use - A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)} - A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D) ## Abstract Various methods and systems are provided for performing nasal high flow therapy. In one example, a method for respiratory support includes: delivering an air and oxygen mixture for nasal high flow therapy to a patient at a flow setting, the flow setting determined based on a peak inspiratory flow obtained during a previous, spontaneous breathing mode during mechanical ventilation of the patient. The flow setting may be a flow rate of a heated and humidified mixture of air and oxygen delivered via a high flow nasal cannula. ## Claims ### Claim 1 A method for respiratory support, comprising: delivering an air and oxygen mixture for nasal high flow therapy to a patient at a flow setting, the flow setting determined via a controller coupled to a ventilator, based on a peak inspiratory flow obtained during a previous, spontaneous breathing mode during invasive mechanical ventilation of the patient with the ventilator, wherein the invasive mechanical ventilation is a different mechanical ventilation than the nasal high flow therapy; and wherein the air and oxygen mixture of the nasal high flow therapy and the air and oxygen mixture of the ventilator are from a same source. ### Claim 2 (depends on 1) The method of claim 1, wherein the delivering the air and oxygen mixture for nasal high flow therapy at the flow setting occurs immediately following the previous, spontaneous breathing mode, without additional flow modes occurring between the previous, spontaneous breathing mode and the nasal high flow therapy. ### Claim 3 (depends on 1) The method of claim 1, wherein the delivering the air and oxygen mixture for nasal high flow therapy at the flow setting occurs immediately following an intermediate breathing mode which occurs immediately following the previous, spontaneous breathing mode, where the intermediate breathing mode includes one of a continuous positive airway pressure mode via an invasive mechanical ventilator and a nasal continuous positive airway pressure mode. ### Claim 4 (depends on 1) The method of claim 1, wherein the flow setting is an initial flow rate of the air and oxygen mixture flowing to the patient from a nasal high flow therapy system. ### Claim 5 (depends on 4) The method of claim 4, further comprising adjusting the initial flow rate based on one or more of patient weight and patient comfort. ### Claim 6 (depends on 1) The method of claim 1, wherein the delivering the air and oxygen mixture for nasal high flow therapy includes delivering the air and oxygen mixture to the patient via a high flow nasal cannula. ### Claim 7 (depends on 1) The method of claim 1, further comprising, via the controller, automatically obtaining the peak inspiratory flow from a waveform output produced during the previous, spontaneous breathing mode during the invasive mechanical ventilation of the patient, automatically determining the flow setting based on the automatically obtained peak inspiratory flow, and, upon transitioning from the invasive mechanical ventilation to the nasal high flow therapy, delivering the air and oxygen mixture for the nasal high flow therapy to the patient at the automatically determined flow setting. ### Claim 8 (depends on 7) The method of claim 7, wherein the controller is in electronic communication with each of an invasive mechanical ventilator and a nasal high flow therapy system. ### Claim 9 (depends on 1) The method of claim 1, further comprising automatically obtaining, via the controller, the peak inspiratory flow from a waveform output produced during the spontaneous breathing mode during the invasive mechanical ventilation of the patient, in response to spontaneous breathing of the patient, during the spontaneous breathing mode, for a threshold duration below a threshold positive end expiratory pressure. ### Claim 10 (depends on 9) The method of claim 9, wherein automatically obtaining the peak inspiratory flow from the waveform output includes averaging the peak inspiratory flow of the waveform output over a predetermined period of time during the spontaneous breathing mode. ### Claim 11 A method for respiratory support, comprising: while operating a respiratory support device, attached to a patient, in a spontaneous breathing mode during invasive mechanical ventilation of the patient, displaying a breathing waveform of the patient, and, in response to successful completion of a spontaneous breathing trial, obtaining a peak inspiratory flow from the breathing waveform; and following the spontaneous breathing mode and after stopping the invasive mechanical ventilation of the patient, delivering an air and oxygen mixture via a nasal high flow therapy system to the patient at a flow rate, wherein the flow rate at start-up of nasal high flow therapy is determined based on the peak inspiratory flow, wherein the invasive mechanical ventilation is a different mechanical ventilation than the nasal high flow therapy. ### Claim 12 (depends on 11) The method of claim 11, further comprising automatically determining the flow rate via a controller in electronic communication with a controller of the respiratory support device and a flow meter of the nasal high flow therapy system, wherein the successful completion of the spontaneous breathing trial is based on an absence of any of apnea, expired minute volume, or respiratory rate alarms occurring during the spontaneous breathing trial. ### Claim 13 (depends on 12) The method of claim 12, wherein automatically determining the flow rate includes trending the breathing waveform over a predetermined period of time, during the spontaneous breathing mode, and averaging peak inspiratory flow measurements for each breath cycle of the trended breathing waveform over the predetermined period of time to obtain an average peak inspiratory flow. ### Claim 14 (depends on 13) The method of claim 13, further comprising setting the flow rate for nasal high flow therapy at a level that is a function of the average peak inspiratory flow. ### Claim 15 (depends on 13) The method of claim 13, further comprising starting the predetermined period of time for trending the breathing waveform only after positive end expiratory pressure is below a threshold level. ### Claim 16 (depends on 11) The method of claim 11, further comprising determining the flow rate for nasal high flow therapy based on the peak inspiratory flow in response to conclusion of the spontaneous breathing trial and a request to wean the patient from the invasive mechanical ventilation. ### Claim 17 A system, comprising: a nasal high flow therapy system; an invasive mechanical ventilator adapted to provide respiratory support to a patient, wherein the invasive mechanical ventilator is a different respiratory support than the nasal high flow therapy; and a control system with one or more controllers with computer readable instructions stored on non-transitory memory that, when executed during operation of the invasive mechanical ventilator, cause the one or more controllers to: execute a spontaneous breathing mode in response to a request for the spontaneous breathing mode; during execution of the spontaneous breathing mode during the invasive mechanical ventilation, acquire flow data from a plurality of breath cycles; and determine a nasal high flow therapy flow setting based on a peak inspiratory flow of the acquired flow data. ### Claim 18 (depends on 17) The system of claim 17, further comprising a user interface with a display, wherein the computer readable instructions further cause the one or more controllers to display a flow waveform of the acquired flow data and the determined nasal high flow therapy flow setting via the display. ### Claim 19 (depends on 17) The system of claim 17, further comprising a nasal high flow therapy system including a high flow cannula adapted to deliver an air and oxygen mixture to the patient, wherein the one or more controllers include computer readable instructions that, when executed during operation of the nasal high flow therapy system, cause the one or more controllers to deliver the air and oxygen mixture for nasal high flow therapy to the patient, via the high flow cannula, at the determined nasal high flow therapy flow setting. ### Claim 20 (depends on 19) The system of claim 19, wherein the nasal high flow therapy system includes a humidifier and a heated circuit coupled with the high flow cannula and wherein the air and oxygen mixture delivered to the patient is a heated and humidified air and oxygen mixture.